TAKING THE SWEET PILL

TAKING THE SWEET PILL

Mon, 03/07/2016 - 14:57

Teva, an international leading pharmaceutical company, is expanding in Bulgaria. GM Nikolay Hadjidontchev tells more on the company's future and why are generics important

Nikolay Hadjidontchev.jpg

Teva's GM Nikolay Hadjidontchev

Sitting in his panorama-view office at the foot of the Vitosha, Nikolay Hadjidontchev, general manager of Teva-Bulgaria, is both excited about the acquisition of Actavis, one of the country's leading pharmaceutical companies, and anxious about the merger's results. Nikolay Hadjidontchev has over 20 years in the pharmaceutical industry and on the consumer goods market. Before becoming the general manager of Teva-Bulgaria in 2011, he was the general manager of Alapis Bulgaria, Actavis Ltd, Roche Bulgaria and Unilever Bulgaria.

Why did TEVA come to Bulgaria in the first place?

In 2000, TEVA started an expansion in Europe with the acquisitions of several companies. The acquisition of German Ratiopharm in 2010 significantly increased Teva's market share in Europe. The company was building up its European presence. Its arrival in Bulgaria in 2007, via a legal entity, was a part of this process. The company needed a foothold in Bulgaria, as the country has always been an interesting, although not especially big, market for generic medicines. Initially, the company was present via its speciality product, a drug for treatment of multiple sclerosis. Later on, it added medicines for cardiovascular and central nervous systems therapeutics, along with products aimed at biometabolism and treatment of respiratory diseases and conditions. The local market grew substantially since Teva-Bulgaria's arrival. In 2015, Teva bought, for $40.5 billion, the generics business of Allergan, and here is how the Teva-Actavis merger in Bulgaria is happening in 2016. When the procedure is finalised, Teva-Bulgaria will become one of the leading pharmaceutical companies on the Bulgarian market. Adding production capabilities to the leading market position will increase significantly the importance that the future company will have for Teva in Europe.

What are the main achievements of Teva since its arrival in Bulgaria?

It is difficult to single out just a few. For me, probably these two: Teva has been a leader in the treatment of multiple sclerosis, and it successfully introduced a new product for the treatment of respiratory diseases.

How will the company's presence influence Bulgaria's healthcare?

Talking about both the present and the future, as an international leader in generic medicines, Teva offers the possibilities to balance spending for prescription and reimbursed drugs. Teva offers high quality, good value for money and lower prices, thus enabling healthcare funds and national healthcare systems to treat more patients with less money. The institutions can also invest the saved money in new innovative medicines for hard-to-treat diseases like cancer, for target and immune therapies, for biological products which are new to the market and are very expensive. If I can sum up in one sentence what Teva does for the Bulgarian healthcare system and will do for it even more after the acquisition, it is that it offers high-quality generic products, enabling the healthcare system to have higher patient access to treatment and to have healthier patients at lower cost.

Is this why generics are important in modern healthcare?

Generics are increasingly important on a global level. All over the world healthcare systems are struggling with increased spending for pharmaceuticals. Generic products save money and lower the treatment price. They help the healthcare systems to meet the challenge of treating more people for longer time. Crucially, their quality is the same as the one of patent products. It is often even better. Think about it: between the introduction of a patent drug and the expiration of its patent, which is about 20 years, the technology changes. So the generic form is often produced with more advanced technology and after refined procedure. Otherwise, the patent and the generic products are identical.

Teva GM Nikolay HadjidontchevTeva also aims to develop innovative medicines.

Teva's innovative or original products are limited to several areas. The company's number one priority is treatment of the central nervous system, specifically multiple sclerosis. The other areas of Teva's interest are the treatment of respiratory diseases and of cancer. In the past few years pharmaceutics has made a significant progress in these fields, especially in oncology. Teva also works on optimising drug absorption by the organism. The more effective it is, the better the treatment results will be. We are also looking at something that might seems like science fiction, but is in the near future: Imagine implantation of chips releasing pharmaceutical active substance into the body of the patient, thus eschewing side effects and stress. These chips can be used for treatment lasting for up to six months. This might seem now science fiction but this is where Teva is looking at the moment.

What was crucial in your decision to join Teva-Bulgaria?

Even when I was managing Actavis, a competitor, I thought about Teva as a place I would like to work. It is the largest generics producer in the world, it has a broad portfolio. And now, after more than four years with Teva, I am looking forward to the new challenges that the acquisition of Actavis will bring. It will be kind of a déjà vu for me.

What's the biggest challenge for you?

Successful integration after the deal is closed. The organisation of a new team doing its best on terms of performance, motivation, knowledge. I am happy that we have really good people working on both sides, in the two companies.

Issue 113
0 comments

Add new comment

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
13 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Discover More

Ambassador Yoram Elron-photo.jpg
YORAM ELRON
Jews and Bulgarians have lived side by side each other for centuries. Bulgaria was among the first countries to recognise the State of Israel, in 1948.

German Gachevski
GERMAN GACHEVSKI: MISSION POSSIBLE
When Vagabond interviews a CEO or an owner of a successful Bulgarian or international company, we usually meet in a flashy office building in Sofia. The meeting with German Gachevski, founder and CEO of software company TSD Services, was more unorthodox.

Philippe Rouvrais
PHILIPPE ROUVRAIS: HOW TO SUCCEED IN TURBULENT TIMES
2020 is a year that forced almost all businesses of importance to redefine their business model in order to survive and even to grow. The IT outsourcing sector is one of the most interesting cases.

Ilonka Raychinova
ILONKA RAYCHINOVA: TAXES MATTER
Nobody likes paying taxes.

P1422193.jpg
NANCY SCHILLER: PHILANTHROPY IN ACTION
Since her arrival four years ago Nancy Schiller has become a well-known personality through Bulgaria.

 (3)_800x600.jpg
SAFECHARGE: WELCOME TO THE FUTURE
As in any crisis, there is a silver lining in the Covid-19 outbreak. The unexpected situation forced individuals and businesses to quickly adapt to the new environment of balancing between protecting public health and staying active.

marieta-yordanova-megasmart.jpg
MARIETA YORDANOVA: UNLEASHING NATURE'S HEALING POTENTIAL
Creating your own company in a field that is still new on the Bulgarian market asks for boldness, the inevitable leap of faith and the will to overcome obstacles to succeed. Marieta Yordanova knows this well.

Radoslav Nedelchev.jpg
RADOSLAV NEDELCHEV: REINVENTING ADVERTISEMENT
Digital advertisement is everywhere nowadays, but it – and customers' behaviour, is changing so rapidly that even established companies and brands struggle to utilise fully its potential.

Blagovest Kirilov.jpg
UNLEASHING THE POTENTIAL OF SERVICES MANAGEMENT OPTIMIZATION
OutsourceBG Services is a Bulgarian company focused on providing high quality tailored IT, information, management and consulting serv

Dimitrios Chronopoulos and Efi Katopi.jpg
DIMITRIOS CHRONOPOULOS & EFI KATOPI
If there is a single trick to open up people's hearts and minds for Greece and things Greek it is Portokalopita, the deliciously different Greek pastry which combines in almost neoclassical proportions shredded phyllo with orange and cinnamon syrup

georgi lozanov 2.jpg
ON COMMUNISM, ANTI-COMMUNISM AND WHAT COMES AFTER
Among his many interests Communism – and what supersedes it – has had a special place on his rostrum.

Irena Joteva.jpg
IRENA JOTEVA: THE ART OF STAYING RELEVANT IN CHANGING TIMES
New technologies have changed the way we work, entertain ourselves, do shopping. They have also changed the way companies work. New regulations and professions are appearing, entire business sectors are transforming beyond recognition.